A study to assess the relative bioavailability of 3 different formulations under fasted and fed condition

Trial Identifier: D5495C00005
Sponsor: AstraZeneca
NCTID:: NCT04024501
Start Date: July 2019
Primary Completion Date: September 2019
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050